CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
Mindfulness Based Relapse Prevention - Smoking and Alcohol +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03734666
NCT03734666N/ACompleted
CompareCT.gov

Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation

H. Lee Moffitt Cancer Center and Research Institute·interventional·Posted Nov 8, 2018·Updated Jan 15, 2026

In Brief

A clinical study evaluating Mindfulness Based Relapse Prevention - Smoking and Alcohol and Cognitive Behavioral Therapy for Tobacco Use and Alcohol Use, Unspecified. Completed, enrolled 67 participants across 1 site.

Detailed Summary

The purpose of this study is to develop a treatment that can effectively help people reduce their alcohol use and quit smoking.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use, Alcohol Use, Unspecified
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Center for Complementary and Integrative Health (NCCIH)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 8, 2018
Enrollment StartJan 14, 2019
Primary CompletionNov 4, 2021
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 7.6 years ago

Interventions

Mindfulness Based Relapse Prevention - Smoking and Alcoholbehavioral

Mindfulness Based Relapse Prevention (MBRP) is a treatment for preventing relapse in addictive disorders that integrates mindfulness meditation with standard relapse prevention practices.

Cognitive Behavioral Therapybehavioral

Cognitive Behavioral Therapy (CBT) is a form of therapy that aims to help individuals modify problematic emotions, behaviors, and thoughts.